David Rubin, MD, of University of Chicago Medicine, and colleagues conducted a randomized, double-blind, placebo-controlled multicenter study evaluating the drug’s safety in 510 adults. Researchers ...
Please provide your email address to receive an email when new articles are posted on . Patients with mild-to-moderate active ulcerative colitis symptoms who received multimatrix mesalazine showed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results